New tool helps kidney patients decide on organ offers

NCT ID NCT05879302

Completed Knowledge-focused Sponsor: Hennepin Healthcare Research Institute Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This pilot study tested a shared decision-making tool called the Donor Offer Plan (DOP) for people on the kidney transplant waiting list. 100 participants reviewed an online education module and discussed their donor preferences with a transplant nurse. The goal was to see if this approach helps patients make more informed choices about accepting donor kidneys, especially those at risk of being discarded.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Donor Offer Plan (DOP) and web-based educational module
What this could lead to: If successful, this tool could help kidney transplant patients make more informed decisions about accepting donor organs, potentially reducing organ discard rates.
What could go wrong: This is a small pilot study (100 participants) testing a behavioral intervention, not a treatment. Results may not apply to all transplant centers or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

END STAGE KIDNEY DISEASE END-STAGE RENAL DISEASE ESRD KIDNEY TRANSPLANTATION

Contacts and locations

Locations

Hennepin Healthcare

Minneapolis, Minnesota, 55415, United States
Mayo Clinic

Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.